Skip to content
PeptideAgent

Clinics in Missouri

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Missouri law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Missouri at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Missouri

No verified clinics serving Missouri are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Missouri

Yes. A Missouri resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Missouri-licensed physician, including by telehealth, but Missouri's telehealth statute (RSMo 191.1146, as amended effective August 28, 2026) requires a properly established physician-patient relationship, an evaluation, a medical history review, and an examination sufficient for diagnosis before prescribing, and it accepts a patient questionnaire only when the treating health care professional reviews it and it holds enough information to stand in for an in-person evaluation. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Missouri Board of Pharmacy; out-of-state pharmacies need a Missouri nonresident pharmacy license (20 CSR 2220-2.025). [1] [2] [3] [4] [5] [6] [7] [8] [10]

Compounded GLP-1 access in Missouri

Missouri requires a real clinical evaluation before a telehealth GLP-1 prescription: since August 28, 2026 a questionnaire counts only when a treating health care professional reviews it and it holds enough information to stand in for an in-person evaluation, and RSMo 334.108 limits prescribing based solely on a telemedicine evaluation. The dispensing pharmacy needs a Missouri or Missouri nonresident license. [2] [3] [6] [11]

Research use only sellers in Missouri

Missouri food and drug law (RSMo chapter 196) prohibits selling adulterated or misbranded drugs, and chapter 338 limits dispensing of prescription drugs to licensed pharmacies. [5] [9] [12]

Missouri notes on specific peptides

  • Semaglutide: Available branded by prescription after a telehealth evaluation and examination that meets RSMo 191.1146 as amended in 2026. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [11]

How to check a clinic in Missouri

  1. Confirm the prescribing clinician's license with the Missouri medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Missouri Board of Pharmacy (Division of Professional Registration) license lookup. [1] [5] [6] [7] [8] [10]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Missouri. [5] [9] [12]

Common questions in Missouri

Can I get a GLP-1 prescription in Missouri from an online questionnaire?

Only in limited cases, and not from an unreviewed form. Since August 28, 2026, RSMo 191.1146 accepts a questionnaire only if the treating health care professional reviews it and it contains enough information to stand in for an in-person evaluation, and the provider must work for or contract with an entity licensed to provide health care in Missouri. RSMo 334.108 separately limits prescribing based solely on a telemedicine evaluation, so expect a clinician review and possibly a live visit. [2] [3] [4]

All peptide legal questions for Missouri

Sources

  1. [1]Missouri Board of Pharmacy
  2. [2]RSMo 191.1146, Physician-patient relationship required for telemedicine, how established
  3. [3]RSMo 334.108, Telemedicine or internet prescriptions, physician-patient relationship required
  4. [4]Missouri HB 2372 (2026) bill summary, health care and telehealth questionnaires (enacted; amended RSMo 191.1146 and 334.108 effective August 28, 2026)
  5. [5]RSMo chapter 338, Pharmacists and pharmacies
  6. [6]20 CSR 2220-2.025, Nonresident pharmacies
  7. [7]20 CSR 2220-2.200, Sterile compounding
  8. [8]20 CSR 2220-2.400, Compounding standards of practice
  9. [9]RSMo chapter 196, Food, drugs and tobacco
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts